期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 66, 期 15, 页码 10354-10363出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.3c00471
关键词
-
A modular peptidomimetic was designed in this study to interact with PCNA and achieve cellular and nuclear permeability, showing promising potential in inhibiting cancer cell proliferation. The peptidomimetic consisted of a p21-derived peptide as the starting scaffold, with a fluorescein tag and SV40 nuclear localization signal attached. The attachment of the fluorescein tag directly influenced the cellular uptake of the peptidomimetic, with fluorescein being essential for nuclear permeability. This work represents an important advancement in the development of PCNA targeting peptidomimetics for anti-cancer agents or cancer diagnostics.
Human proliferating cell nuclearantigen (PCNA) is acritical mediatorof DNA replication and repair, acting as a docking platform for replicationproteins. Disrupting these interactions with a peptidomimetic agentpresents as a promising avenue to limit proliferation of cancerouscells. Here, a p21-derived peptide was employed as a starting scaffoldto design a modular peptidomimetic that interacts with PCNA and iscellular and nuclear permeable. Ultimately, a peptidomimetic was producedwhich met these criteria, consisting of a fluorescein tag and SV40nuclear localization signal conjugated to the N-terminusof a p21 macrocycle derivative. Attachment of the fluorescein tagwas found to directly affect cellular uptake of the peptidomimetic,with fluorescein being requisite for nuclear permeability. This workprovides an important step forward in the development of PCNA targetingpeptidomimetics for use as anti-cancer agents or as cancer diagnostics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据